Efficacy and Safety of Ruxolitinib in Neuromyelitis Optica Spectrum Disorders
Clinical trial NCT05909943 · WITHDRAWN
Trial details
- NCT number
- NCT05909943
- Sponsor
- Tianjin Medical University General Hospital
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2026-02-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.